Effects of stimulating interleukin -2/anti- interleukin -2 antibody complexes on renal cell carcinoma

BACKGROUND: Current therapies for advanced renal cell carcinoma (RCC) have low cure rates or significant side effects. It has been reported that complexes composed of interleukin (IL)-2 and stimulating anti-IL-2 antibody (IL-2C) suppress malignant melanoma growth. We investigated whether it could ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Kyu-Hyun, Kim, Ki Won, Yan, Ji-Jing, Lee, Jae-Ghi, Lee, Eun Mi, Han, Miyeon, Cho, Eun Jin, Kang, Seong Sik, Lim, Hye Jin, Koo, Tai Yeon, Ahn, Curie, Yang, Jaeseok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715282/
https://www.ncbi.nlm.nih.gov/pubmed/26772545
http://dx.doi.org/10.1186/s12894-016-0121-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715282/
https://www.ncbi.nlm.nih.gov/pubmed/26772545
http://dx.doi.org/10.1186/s12894-016-0121-2

Ejemplares similares